The global Complement Drug for Blood Disease market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Complement Drug for Blood Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Drug for Blood Disease. This report contains market size and forecasts of Complement Drug for Blood Disease in global, including the following market information:
- Global Complement Drug for Blood Disease Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Peptides Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Complement Drug for Blood Disease include Amyndas, Apellis, Novartis, Roche, Regeneron, Amgen, Samsung Bioepis, Alnylam and Akari Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Complement Drug for Blood Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Complement Drug for Blood Disease Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Complement Drug for Blood Disease Market Segment Percentages, by Type, 2022 (%)
- Peptides
- Antibodies
- Others
Global Complement Drug for Blood Disease Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Complement Drug for Blood Disease Market Segment Percentages, by Application, 2022 (%)
Global Complement Drug for Blood Disease Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Complement Drug for Blood Disease Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Complement Drug for Blood Disease revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Complement Drug for Blood Disease revenues share in global market, 2022 (%)
Key players include:
- Amyndas
- Apellis
- Novartis
- Roche
- Regeneron
- Amgen
- Samsung Bioepis
- Alnylam
- Akari Therapeutics
- UCB
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complement Drug for Blood Disease, market overview.
Chapter 2: Global Complement Drug for Blood Disease market size in revenue.
Chapter 3: Detailed analysis of Complement Drug for Blood Disease company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complement Drug for Blood Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Complement Drug for Blood Disease Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Complement Drug for Blood Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Complement Drug for Blood Disease Overall Market Size
2.1 Global Complement Drug for Blood Disease Market Size: 2022 VS 2032
2.2 Global Complement Drug for Blood Disease Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Complement Drug for Blood Disease Players in Global Market
3.2 Top Global Complement Drug for Blood Disease Companies Ranked by Revenue
3.3 Global Complement Drug for Blood Disease Revenue by Companies
3.4 Top 3 and Top 5 Complement Drug for Blood Disease Companies in Global Market, by Revenue in 2022
3.5 Global Companies Complement Drug for Blood Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Complement Drug for Blood Disease Players in Global Market
3.6.1 List of Global Tier 1 Complement Drug for Blood Disease Companies
3.6.2 List of Global Tier 2 and Tier 3 Complement Drug for Blood Disease Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Complement Drug for Blood Disease Market Size Markets, 2022 & 2032
4.1.2 Peptides
4.1.3 Antibodies
4.1.4 Others
4.2 By Type - Global Complement Drug for Blood Disease Revenue & Forecasts
4.2.1 By Type - Global Complement Drug for Blood Disease Revenue, 2018-2023
4.2.2 By Type - Global Complement Drug for Blood Disease Revenue, 2024-2032
4.2.3 By Type - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Complement Drug for Blood Disease Market Size, 2022 & 2032
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Complement Drug for Blood Disease Revenue & Forecasts
5.2.1 By Application - Global Complement Drug for Blood Disease Revenue, 2018-2023
5.2.2 By Application - Global Complement Drug for Blood Disease Revenue, 2024-2032
5.2.3 By Application - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Complement Drug for Blood Disease Market Size, 2022 & 2032
6.2 By Region - Global Complement Drug for Blood Disease Revenue & Forecasts
6.2.1 By Region - Global Complement Drug for Blood Disease Revenue, 2018-2023
6.2.2 By Region - Global Complement Drug for Blood Disease Revenue, 2024-2032
6.2.3 By Region - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Complement Drug for Blood Disease Revenue, 2018-2032
6.3.2 US Complement Drug for Blood Disease Market Size, 2018-2032
6.3.3 Canada Complement Drug for Blood Disease Market Size, 2018-2032
6.3.4 Mexico Complement Drug for Blood Disease Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Complement Drug for Blood Disease Revenue, 2018-2032
6.4.2 Germany Complement Drug for Blood Disease Market Size, 2018-2032
6.4.3 France Complement Drug for Blood Disease Market Size, 2018-2032
6.4.4 U.K. Complement Drug for Blood Disease Market Size, 2018-2032
6.4.5 Italy Complement Drug for Blood Disease Market Size, 2018-2032
6.4.6 Russia Complement Drug for Blood Disease Market Size, 2018-2032
6.4.7 Nordic Countries Complement Drug for Blood Disease Market Size, 2018-2032
6.4.8 Benelux Complement Drug for Blood Disease Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Complement Drug for Blood Disease Revenue, 2018-2032
6.5.2 China Complement Drug for Blood Disease Market Size, 2018-2032
6.5.3 Japan Complement Drug for Blood Disease Market Size, 2018-2032
6.5.4 South Korea Complement Drug for Blood Disease Market Size, 2018-2032
6.5.5 Southeast Asia Complement Drug for Blood Disease Market Size, 2018-2032
6.5.6 India Complement Drug for Blood Disease Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Complement Drug for Blood Disease Revenue, 2018-2032
6.6.2 Brazil Complement Drug for Blood Disease Market Size, 2018-2032
6.6.3 Argentina Complement Drug for Blood Disease Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, 2018-2032
6.7.2 Turkey Complement Drug for Blood Disease Market Size, 2018-2032
6.7.3 Israel Complement Drug for Blood Disease Market Size, 2018-2032
6.7.4 Saudi Arabia Complement Drug for Blood Disease Market Size, 2018-2032
6.7.5 UAE Complement Drug for Blood Disease Market Size, 2018-2032
7 Complement Drug for Blood Disease Companies Profiles
7.1 Amyndas
7.1.1 Amyndas Company Summary
7.1.2 Amyndas Business Overview
7.1.3 Amyndas Complement Drug for Blood Disease Major Product Offerings
7.1.4 Amyndas Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.1.5 Amyndas Key News & Latest Developments
7.2 Apellis
7.2.1 Apellis Company Summary
7.2.2 Apellis Business Overview
7.2.3 Apellis Complement Drug for Blood Disease Major Product Offerings
7.2.4 Apellis Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.2.5 Apellis Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Complement Drug for Blood Disease Major Product Offerings
7.3.4 Novartis Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Complement Drug for Blood Disease Major Product Offerings
7.4.4 Roche Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Regeneron
7.5.1 Regeneron Company Summary
7.5.2 Regeneron Business Overview
7.5.3 Regeneron Complement Drug for Blood Disease Major Product Offerings
7.5.4 Regeneron Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.5.5 Regeneron Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Complement Drug for Blood Disease Major Product Offerings
7.6.4 Amgen Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Samsung Bioepis
7.7.1 Samsung Bioepis Company Summary
7.7.2 Samsung Bioepis Business Overview
7.7.3 Samsung Bioepis Complement Drug for Blood Disease Major Product Offerings
7.7.4 Samsung Bioepis Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.7.5 Samsung Bioepis Key News & Latest Developments
7.8 Alnylam
7.8.1 Alnylam Company Summary
7.8.2 Alnylam Business Overview
7.8.3 Alnylam Complement Drug for Blood Disease Major Product Offerings
7.8.4 Alnylam Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.8.5 Alnylam Key News & Latest Developments
7.9 Akari Therapeutics
7.9.1 Akari Therapeutics Company Summary
7.9.2 Akari Therapeutics Business Overview
7.9.3 Akari Therapeutics Complement Drug for Blood Disease Major Product Offerings
7.9.4 Akari Therapeutics Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.9.5 Akari Therapeutics Key News & Latest Developments
7.10 UCB
7.10.1 UCB Company Summary
7.10.2 UCB Business Overview
7.10.3 UCB Complement Drug for Blood Disease Major Product Offerings
7.10.4 UCB Complement Drug for Blood Disease Revenue in Global Market (2018-2023)
7.10.5 UCB Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Complement Drug for Blood Disease Market Opportunities & Trends in Global Market
Table 2. Complement Drug for Blood Disease Market Drivers in Global Market
Table 3. Complement Drug for Blood Disease Market Restraints in Global Market
Table 4. Key Players of Complement Drug for Blood Disease in Global Market
Table 5. Top Complement Drug for Blood Disease Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Complement Drug for Blood Disease Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Complement Drug for Blood Disease Revenue Share by Companies, 2018-2023
Table 8. Global Companies Complement Drug for Blood Disease Product Type
Table 9. List of Global Tier 1 Complement Drug for Blood Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complement Drug for Blood Disease Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Complement Drug for Blood Disease Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Complement Drug for Blood Disease Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Complement Drug for Blood Disease Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Complement Drug for Blood Disease Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Complement Drug for Blood Disease Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Complement Drug for Blood Disease Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Complement Drug for Blood Disease Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Complement Drug for Blood Disease Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Complement Drug for Blood Disease Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue, (US$, Mn), 2024-2032
Table 30. Amyndas Company Summary
Table 31. Amyndas Complement Drug for Blood Disease Product Offerings
Table 32. Amyndas Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 33. Amyndas Key News & Latest Developments
Table 34. Apellis Company Summary
Table 35. Apellis Complement Drug for Blood Disease Product Offerings
Table 36. Apellis Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 37. Apellis Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Complement Drug for Blood Disease Product Offerings
Table 40. Novartis Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Complement Drug for Blood Disease Product Offerings
Table 44. Roche Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Regeneron Company Summary
Table 47. Regeneron Complement Drug for Blood Disease Product Offerings
Table 48. Regeneron Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 49. Regeneron Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Complement Drug for Blood Disease Product Offerings
Table 52. Amgen Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Samsung Bioepis Company Summary
Table 55. Samsung Bioepis Complement Drug for Blood Disease Product Offerings
Table 56. Samsung Bioepis Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 57. Samsung Bioepis Key News & Latest Developments
Table 58. Alnylam Company Summary
Table 59. Alnylam Complement Drug for Blood Disease Product Offerings
Table 60. Alnylam Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 61. Alnylam Key News & Latest Developments
Table 62. Akari Therapeutics Company Summary
Table 63. Akari Therapeutics Complement Drug for Blood Disease Product Offerings
Table 64. Akari Therapeutics Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 65. Akari Therapeutics Key News & Latest Developments
Table 66. UCB Company Summary
Table 67. UCB Complement Drug for Blood Disease Product Offerings
Table 68. UCB Complement Drug for Blood Disease Revenue (US$, Mn) & (2018-2023)
Table 69. UCB Key News & Latest Developments
List of Figures
Figure 1. Complement Drug for Blood Disease Segment by Type in 2022
Figure 2. Complement Drug for Blood Disease Segment by Application in 2022
Figure 3. Global Complement Drug for Blood Disease Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Complement Drug for Blood Disease Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Complement Drug for Blood Disease Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Complement Drug for Blood Disease Revenue in 2022
Figure 8. By Type - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 9. By Application - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 10. By Type - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 12. By Application - Global Complement Drug for Blood Disease Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 14. By Region - Global Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 15. By Country - North America Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 16. US Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 20. Germany Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 21. France Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 28. China Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 32. India Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 34. Brazil Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Complement Drug for Blood Disease Revenue Market Share, 2018-2032
Figure 37. Turkey Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Complement Drug for Blood Disease Revenue, (US$, Mn), 2018-2032
Figure 41. Amyndas Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Apellis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Regeneron Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Samsung Bioepis Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Alnylam Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Akari Therapeutics Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. UCB Complement Drug for Blood Disease Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
